chenodeoxycholic acid has been researched along with Esophageal Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akanuma, N; Akutsu, Y; Hanari, N; Hoshino, I; Isozaki, Y; Maruyama, T; Matsubara, H; Mori, M; Murakami, K; Nakayama, T; Nishimori, T; Suito, H; Suzuki, A; Takahashi, M; Takeshita, N; Toyozumi, T | 1 |
| Geng, J; Gong, J; Song, Y; Wu, J | 1 |
| Blain, SW; Gress, F; Nguyen, KD; Treem, WR | 1 |
| Attwood, SE; Hardy, R; Harper, E; Harrison, R; Jankowski, JA; Luong, QT; Morris, CD; Perry, I; Tselepis, C; Wakelin, D | 1 |
| Kim, KH; Kwon, TK; Lee, SJ; Park, BJ; Park, SW; Roh, JL; Sung, MW | 1 |
| Imamura, M; Kaganoi, J; Kawabe, A; Kondo, K; Shimada, Y; Soma, T; Tsunoda, S | 1 |
| Hainaut, P; Hautefeuille, A; Mion, F; Pétré, A; Roman, S; Scoazec, JY; Thépot, A | 1 |
| Ajani, J; Buttar, NS; Chen, CT; Chou, CK; Guha, S; Hsu, JM; Huang, P; Hung, MC; Izzo, JG; Kuo, HP; Lee, DF; Sun, HL; Wang, KK; Wei, Y; Wu, TT; Yen, CJ | 1 |
8 other study(ies) available for chenodeoxycholic acid and Esophageal Neoplasms
| Article | Year |
|---|---|
Screening of alternative drugs to the tumor suppressor miR-375 in esophageal squamous cell carcinoma using the connectivity map.
Topics: Antineoplastic Agents; Apoptosis; Benzocaine; Betazole; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Chenodeoxycholic Acid; Cytotoxins; DNA Primers; Esophageal Neoplasms; Humans; In Situ Nick-End Labeling; Metformin; MicroRNAs; Nizatidine; Organophosphates; Proline; Protein Array Analysis; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Transcriptome; Transfection; Tumor Suppressor Proteins | 2014 |
Deoxycholic acid induces the overexpression of intestinal mucin, MUC2, via NF-kB signaling pathway in human esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Analysis of Variance; Aspirin; Cell Line, Tumor; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cyclic AMP-Dependent Protein Kinases; Deoxycholic Acid; Esophageal Neoplasms; Gastrointestinal Agents; Gene Expression Regulation, Neoplastic; Humans; Mucin-2; Naphthalenes; NF-kappa B; Protein Kinase C; RNA, Small Interfering; Signal Transduction; Taurocholic Acid | 2008 |
Inflammatory mediators of esophagitis alter p27 Kip1 expression in esophageal epithelial cells.
Topics: Barrett Esophagus; Biological Transport; Biomarkers; Cell Line; Cell Nucleus; Cell Proliferation; Chenodeoxycholic Acid; Cyclin-Dependent Kinase Inhibitor p27; Cytoplasm; Eosinophil Granule Proteins; Eosinophilic Esophagitis; Eosinophils; Epithelial Cells; Esophageal Neoplasms; Flow Cytometry; Gastroesophageal Reflux; Humans; Hydrochloric Acid; Inflammation Mediators | 2010 |
Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro.
Topics: Adenocarcinoma; Barrett Esophagus; Bile Acids and Salts; Blotting, Western; Cell Division; Chenodeoxycholic Acid; Deoxycholic Acid; Esophageal Neoplasms; Fluorescent Antibody Technique; Gastroesophageal Reflux; Gene Expression Regulation; Genes, myc; Humans; Immunohistochemistry; Polymerase Chain Reaction; Tumor Cells, Cultured; Up-Regulation | 2003 |
Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux.
Topics: Bile Acids and Salts; Cell Transformation, Neoplastic; Chenodeoxycholic Acid; Cyclooxygenase 2; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Induction; Esophageal Neoplasms; Gastroesophageal Reflux; Humans; Isoenzymes; Laryngeal Neoplasms; Larynx; Membrane Proteins; Pharyngeal Neoplasms; Pharynx; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Tumor Cells, Cultured | 2003 |
Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: A possible mechanism of angiogenesis in patients with esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Cell Line, Tumor; Chenodeoxycholic Acid; Cyclooxygenase 2; Dinoprostone; Disease Progression; Enzyme Activation; ErbB Receptors; Esophageal Neoplasms; Female; Gene Expression Regulation, Enzymologic; Humans; Interleukin-6; Male; Mice; Middle Aged; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Signal Transduction; Survival Rate; Vascular Endothelial Growth Factor A | 2006 |
Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture.
Topics: Acetylcysteine; Apoptosis; Barrett Esophagus; Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Chenodeoxycholic Acid; Cyclooxygenase 2; Deoxycholic Acid; DNA-Binding Proteins; Down-Regulation; Doxorubicin; Esophageal Neoplasms; Esophagus; Fluorescent Antibody Technique; Humans; Hydrogen-Ion Concentration; Leupeptins; Proteasome Inhibitors; Taurochenodeoxycholic Acid; Trans-Activators; Transcription Factors; Tumor Suppressor Proteins | 2007 |
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Topics: Adenocarcinoma; Barrett Esophagus; Bile Acids and Salts; Cell Division; Chenodeoxycholic Acid; Esophageal Neoplasms; Gastroesophageal Reflux; Gene Expression Regulation, Neoplastic; Humans; Inflammation; NF-kappa B; Nitriles; Protein Kinases; RNA, Small Interfering; Sirolimus; Sulfones; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Ursodeoxycholic Acid | 2008 |